P glycoprotein in human immunodeficiency virus type 1 infection and therapy. - Wikidata - awgldk - TriplyDB

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

http://www.wikidata.org/entity/Q35718765

about

Evaluation of memory enhancing clinically available standardized extract of Bacopa monniera on P-glycoprotein and cytochrome P450 3A in Sprague-Dawley rats No evidence for induction of ABC transporters in peripheral blood mononuclear cells in humans after 14 days of efavirenz treatment.Pharmacokinetics of tenofovir disoproxil fumarate and ritonavir-boosted saquinavir mesylate administered alone or in combination at steady state The effects of human immunodeficiency virus infection on the expression of the drug efflux proteins P-glycoprotein and breast cancer resistance protein in a human intestine model Drug-drug interaction analysis of pyronaridine/artesunate and ritonavir in healthy volunteers.Pharmacologic perspectives for once-daily antiretroviral therapy.Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity.Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.HIV-1 Alters Intestinal Expression of Drug Transporters and Metabolic Enzymes: Implications for Antiretroviral Drug Disposition Engineering strategies to enhance nanoparticle-mediated oral delivery.The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research.Marine natural products with P-glycoprotein inhibitor properties.HIV/AIDS patients display lower relative bioavailability of efavirenz than healthy subjects.Interaction of Rifampin and Darunavir-Ritonavir or Darunavir-Cobicistat In Vitro Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein.Bayesian survival analysis in genetic association studies.ABCB1 polymorphisms and the concentrations of lopinavir and ritonavir in blood, semen and saliva of HIV-infected men under antiretroviral therapy.Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).

P2860

Q28535796-E02A14FD-C7E1-455E-B5A6-C80536886C8E Q34151189-05022477-21F5-4B5A-AFCA-4EDABCC59E85 Q34510726-5A21AE4F-DCA2-4BF7-8146-A5FB781606C2 Q35013818-22B256F3-B3C0-45AC-A3E1-26C14C2761AF Q35771822-6106E879-11CC-4F60-B8D9-5C3A93985A7D Q35915916-22B80A4F-DF32-4AF6-ACC2-5EE5CBFA7932 Q36132255-4143017D-B097-4C80-B807-7CEBF193F40A Q36376533-3B5C5F47-9E13-4D8D-94D3-4103B5944D58 Q36888037-4E335A27-F652-45A8-9CE9-0E2DC92624A5 Q37328673-5A1A6F40-22D4-4098-8604-A91E7A44AF24 Q37379470-1F5E3F48-14CC-4808-9D72-B8C3D7C5C6F4 Q37566253-C965C366-50E3-4003-95CF-28E1664E5ECB Q38869853-A8FC12E4-3CA3-4E70-A2B6-45C37B225C15 Q38963389-3210D1EA-8174-4068-8080-4B6903EADF00 Q39013665-6A82073B-A58F-40D8-95DA-9B3EDF397690 Q41983289-09ACFB42-5BE9-4294-94D9-6D879F4D4B0E Q46126663-EE39A13B-8A51-468C-BC10-65ECCCA138AD Q46955645-7A026C82-1ACA-4AC0-9CB5-BDAF2902147D Q50335627-ADFEFA3A-762D-4D6F-8389-6B271B74A861

P2860

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

http://www.wikidata.org/entity/Q35718765

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@ast

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@en

type

label

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@ast

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@en

prefLabel

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@ast

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@en

P1433

Q35718765-1AAF4B9F-E949-4791-821C-62E503410092

P1476

Q35718765-1DD61928-DC89-4683-AAC7-CE4750F473F4

P2093

Q35718765-034B5BB4-4ED5-4672-9305-F5F04A803E59

Q35718765-530F4CDD-6A66-49A2-AEB7-F66EC29AF4B0

Q35718765-6ABAFECB-7F86-4C67-8A29-308F7AA00B28

Q35718765-73AAA131-D71B-4533-85B3-81B11BE2E736

Q35718765-A1EB5DFE-C6B7-49C2-8A76-7063A0E69B22

P2860

Q35718765-01F9E229-74E8-4949-BE6C-1C83DA330165

Q35718765-06945B1A-4123-45C8-8E8E-8B5409BAF66F

Q35718765-06E99BB7-0E7C-40A5-9DFC-ABDA71BCB3CF

Q35718765-086EF563-E384-412B-8B11-99A02DF6B78B

Q35718765-0895D6D1-1783-406C-B8A1-A6CBE62F4298

Q35718765-098EF4C5-913D-4F75-B843-35AD818CF6B7

Q35718765-09A852B6-1B07-4245-B83E-5D1DD500AED2

Q35718765-0A669704-E4E9-402D-BCE6-E0C04411707B

Q35718765-0A7E2B15-B53C-4E75-A763-97786AAA175A

Q35718765-0D841212-6C28-4E88-861B-AF8884DDD625

P304

Q35718765-31B8E238-8E8B-43A8-8984-E83A326DA3D8

P31

Q35718765-4F77CD5D-2455-453C-8815-615836A3E5F7

P356

Q35718765-6EE2417E-81A6-4354-96AC-4086AFEF95BD

P407

Q35718765-9EC43868-3092-42E8-AC4F-8056AD02BA58

P433

Q35718765-53548314-98BA-4054-90AD-3B6F53B6B624

P478

Q35718765-BB6EC787-902D-4510-B38B-992FE589E7EA

P577

Q35718765-F4FE2C68-0616-4A5B-85C2-3574A31572C4

P698

Q35718765-E4FF559F-5261-41C1-840F-60D407AE480E

P932

Q35718765-FC03F149-9B82-4492-8A3D-EA2B8D11B335

P356

AAC.48.4.1073-1081.2004

P1433

Antimicrobial Agents and Chemotherapy

P1476

P glycoprotein in human immunodeficiency virus type 1 infection and therapy.

@en

P2093

Alfred H Schinkel

http://www.w3.org/2001/XMLSchema#string

Jan M Prins

http://www.w3.org/2001/XMLSchema#string

Joep M A Lange

http://www.w3.org/2001/XMLSchema#string

Jos H Beijnen

http://www.w3.org/2001/XMLSchema#string

Sanjay U C Sankatsing

http://www.w3.org/2001/XMLSchema#string

P2860

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

Biochemistry of multidrug resistance mediated by the multidrug transporter

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

Inhibitory effect of human immunodeficiency virus protease inhibitors on multidrug resistance transporter P-glycoproteins.

P304

1073-1081

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.48.4.1073-1081.2004

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15047504

http://www.w3.org/2001/XMLSchema#string

P932

375313

http://www.w3.org/2001/XMLSchema#string